- Home
- BMRA vs EVOK Comparison
BMRA vs EVOK Comparison
Compare BMRA & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRA
- EVOK
- Stock Information
- Founded
- BMRA 1971
- EVOK 2007
- Country
- BMRA United States
- EVOK United States
- Employees
- BMRA N/A
- EVOK N/A
- Industry
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- BMRA Health Care
- EVOK Health Care
- Exchange
- BMRA Nasdaq
- EVOK Nasdaq
- Market Cap
- BMRA 8.2M
- EVOK 7.6M
- IPO Year
- BMRA N/A
- EVOK 2013
- Fundamental
- Price
- BMRA $2.45
- EVOK $10.69
- Analyst Decision
- BMRA
- EVOK
- Analyst Count
- BMRA 0
- EVOK 0
- Target Price
- BMRA N/A
- EVOK N/A
- AVG Volume (30 Days)
- BMRA 30.0K
- EVOK 237.3K
- Earning Date
- BMRA 10-14-2025
- EVOK 11-13-2025
- Dividend Yield
- BMRA N/A
- EVOK N/A
- EPS Growth
- BMRA N/A
- EVOK N/A
- EPS
- BMRA N/A
- EVOK N/A
- Revenue
- BMRA $4,884,000.00
- EVOK $14,424,652.00
- Revenue This Year
- BMRA N/A
- EVOK $57.38
- Revenue Next Year
- BMRA N/A
- EVOK $59.57
- P/E Ratio
- BMRA N/A
- EVOK N/A
- Revenue Growth
- BMRA N/A
- EVOK 67.40
- 52 Week Low
- BMRA $2.08
- EVOK $1.94
- 52 Week High
- BMRA $10.16
- EVOK $10.79
- Technical
- Relative Strength Index (RSI)
- BMRA 33.88
- EVOK 84.12
- Support Level
- BMRA $2.36
- EVOK $4.50
- Resistance Level
- BMRA $2.56
- EVOK $10.72
- Average True Range (ATR)
- BMRA 0.12
- EVOK 0.19
- MACD
- BMRA -0.02
- EVOK 0.37
- Stochastic Oscillator
- BMRA 13.64
- EVOK 98.39
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.